Larisa Meleks
Family Medicine · North Port, FLNPI 1568567857
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $989 and has fallen 92.2% since, to $77 in 2021.
Across 131 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$225
- GSK$193
- Johnson & Johnson$159
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$141
- Merck$138
- Pfizer$131
- plus $927 from 20 others
What the payments were for
- Food & beverage$1,914100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $225 |
| GSK | 18 | $193 |
| Johnson & Johnson | 10 | $159 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $141 |
| Merck | 10 | $138 |
| Pfizer | 9 | $131 |
| Amgen | 9 | $111 |
| AstraZeneca | 9 | $109 |
| Lilly USA, LLC | 7 | $98 |
| Radius Health, Inc. | 6 | $92 |
| Sanofi-aventis U.S. LLC | 5 | $80 |
| Kowa Pharmaceuticals America, Inc. | 4 | $70 |
| Amarin Pharma, Inc. | 3 | $63 |
| Novartis | 4 | $58 |
| Boehringer Ingelheim | 3 | $40 |
| Astellas Pharma US Inc | 2 | $36 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| AbbVie | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $9 |
How this compares
$1,914 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.
Other family medicine in North Port
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.